製品、技術、用途、競合状況、エンドユーザー、地域別 ジェノタイピングアッセイ市場:2031年までの世界予測Genotyping Assay Market by Product, Technology, Application, Competition, End User, Region Global Forecast to 2031 世界のジェノタイピングアッセイ市場は、2026年の242.9億米ドルから2031年までに446.0億米ドルに達すると予測されており、予測期間中の年平均成長率(CAGR)は12.9%となる見込みです。 市場の成長は、DNAシーケ... もっと見る
英語原文をAIを使って翻訳しています。
サマリー世界のジェノタイピングアッセイ市場は、2026年の242.9億米ドルから2031年までに446.0億米ドルに達すると予測されており、予測期間中の年平均成長率(CAGR)は12.9%となる見込みです。 市場の成長は、DNAシーケンシング技術の進歩、遺伝性疾患の有病率の上昇、個別化医療の普及拡大、および創薬・医薬品開発におけるジェノタイピングの利用拡大によって牽引されています。 PCRベースのアッセイ、マイクロアレイ技術、シーケンシングプラットフォーム、およびバイオインフォマティクスソリューションにおける継続的なイノベーションが、市場の普及をさらに後押ししている。しかし、機器の導入・維持コストの高さ、データ管理上の課題、遺伝データのプライバシーに関する懸念、およびゲノム解析の熟練した専門家の不足が、市場のさらなる成長を抑制すると予想される。 2025年、製品別に見ると、ジェノタイピングアッセイ市場において、試薬・キット部門が最大のシェアを占めた。 2026年から2031年にかけて、技術別に見ると、シーケンシング分野がジェノタイピングアッセイ市場において最も高い成長率を示すと予測されている。 2026年から2031年にかけて、ジェノタイピングアッセイ市場において、アジア太平洋地域が最も高い年平均成長率(CAGR)で成長すると予測されている。 本レポートのために実施された一次インタビューは、次のように分類できます。 本レポートで取り上げられている企業のリスト 調査対象分野 本レポートを購入する主なメリット 本レポートでは、以下のポイントについて洞察を提供しています: 目次1 はじめに 33 2 概要 38 3 プレミアム・インサイト 45 4 市場の概要 49 5 遺伝子型判定アッセイ市場:製品・サービス別 81 6 遺伝子型判定アッセイ市場(技術別) 106 7 遺伝子型判定アッセイ市場(用途別) 154 8 遺伝子型判定アッセイ市場(エンドユーザー別) 170 9 地域別ジェノタイピングアッセイ市場 184 10 競争環境 286 11 企業概要 303 12 研究方法論 382 13 付録 394 図表リストFIGURE 1 GENOTYPING ASSAY MARKET: MARKET SEGMENTATION AND REGIONAL SCOPE 34.FIGURE 2 GENOTYPING ASSAY MARKET: YEARS CONSIDERED 36. FIGURE 3 MARKET SCENARIO 39. FIGURE 4 GLOBAL GENOTYPING ASSAY MARKET, 2023–2031 39. FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN GENOTYPING ASSAY MARKET, JANUARY 2023–OCTOBER 2026 40. FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF GENOTYPING ASSAY MARKET 41. FIGURE 7 HIGH-GROWTH SEGMENTS IN GENOTYPING ASSAY MARKET, 2026–2031 42. FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN GENOTYPING ASSAY MARKET DURING FORECAST PERIOD 43. FIGURE 9 GROWING GENOMIC TESTING INFRASTRUCTURE TO PROPEL MARKET GROWTH 45. FIGURE 10 REAGENTS & KITS SEGMENT ACCOUNTED FOR LARGEST SHARE OF GENOTYPING ASSAY MARKET IN NORTH AMERICA IN 2025 46. FIGURE 11 JAPAN TO BE FASTEST-GROWING COUNTRY IN GENOTYPING ASSAY MARKET DURING FORECAST PERIOD 47. FIGURE 12 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 48. FIGURE 13 GENOTYPING ASSAY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49. FIGURE 14 GENOTYPING ASSAY MARKET: PORTER’S FIVE FORCES ANALYSIS 57. FIGURE 15 GENOTYPING ASSAY MARKET: VALUE CHAIN ANALYSIS 61. FIGURE 16 GENOTYPING ASSAY MARKET ECOSYSTEM 62. FIGURE 17 PATENT APPLICATIONS FOR GENOTYPING ASSAY MARKET, JANUARY 2015–JANUARY 2025 66. FIGURE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 68. FIGURE 19 KEY BUYING CRITERIA FOR GENOTYPING ASSAYS 69. FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75. FIGURE 21 NORTH AMERICA: GENOTYPING ASSAY MARKET SNAPSHOT 186. FIGURE 22 ASIA PACIFIC: GENOTYPING ASSAY MARKET SNAPSHOT 236. FIGURE 23 REVENUE ANALYSIS OF KEY PLAYERS IN GENOTYPING. ASSAY MARKET, 2023–2025 288. FIGURE 24 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GENOTYPING. ASSAY MARKET, 2025 289. FIGURE 25 GENOTYPING ASSAY MARKET: COMPANY EVALUATION MATRIX. (KEY PLAYERS), 2025 291. FIGURE 26 GENOTYPING ASSAY MARKET: COMPANY FOOTPRINT 292. FIGURE 27 GENOTYPING ASSAY MARKET: COMPANY EVALUATION MATRIX. (STARTUPS/SMES), 2025 296. FIGURE 28 EV/EBITDA OF KEY VENDORS 298. FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 298. FIGURE 30 GENOTYPING ASSAY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 299. FIGURE 31 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 304. FIGURE 32 ILLUMINA, INC.: COMPANY SNAPSHOT (2025) 312. FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 323. FIGURE 34 QIAGEN: COMPANY SNAPSHOT (2025) 329. FIGURE 35 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 337. FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025) 342. FIGURE 37 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 346. FIGURE 38 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 354. FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2025) 360. FIGURE 40 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2025) 365. FIGURE 41 GENOTYPING ASSAY MARKET: RESEARCH DESIGN 382. FIGURE 42 KEY PRIMARY SOURCES: DEMAND AND SUPPLY SIDES 384. FIGURE 43 GENOTYPING ASSAY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025 385. FIGURE 44 GENOTYPING ASSAY MARKET ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025 386. FIGURE 45 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2025) 386. FIGURE 46 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 387. FIGURE 47 SEGMENTAL MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN 388. FIGURE 48 GENOTYPING ASSAY MARKET: CAGR PROJECTIONS 389. FIGURE 49 DATA TRIANGULATION METHODOLOGY 391. TABLE 1 GENOTYPING ASSAY MARKET: INCLUSIONS & EXCLUSIONS 35. TABLE 2 GENOTYPING ASSAY MARKET: IMPACT ANALYSIS 50. TABLE 3 HUMAN GENOME SEQUENCING COST TIMELINE, 2003–2025 51. TABLE 4 GENOTYPING ASSAY MARKET: PORTER’S FIVE FORCES ANALYSIS 57. TABLE 5 GENOTYPING ASSAY MARKET: ROLE IN ECOSYSTEM 62. TABLE 6 AVERAGE SELLING PRICE OF GENOTYPING ASSAY PRODUCTS, BY KEY PLAYER, 2021–2025 64. TABLE 7 AVERAGE SELLING PRICE OF GENOTYPING ASSAY PRODUCTS,. BY REGION, 2021–2025 65. TABLE 8 INDICATIVE LIST OF PATENTS IN GENOTYPING ASSAY MARKET 67. TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 68. TABLE 10 KEY BUYING CRITERIA FOR GENOTYPING ASSAYS 69. TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION 71. TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71. TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES 72. TABLE 14 GENOTYPING ASSAY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 75. TABLE 15 GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 82. TABLE 16 GENOTYPING ASSAY REAGENTS & KITS MARKET, BY REGION, 2023–2031 (USD MILLION) 83. TABLE 17 NORTH AMERICA: GENOTYPING ASSAY REAGENTS & KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 83. TABLE 18 EUROPE: GENOTYPING ASSAY REAGENTS & KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 84. TABLE 19 ASIA PACIFIC: GENOTYPING ASSAY REAGENTS & KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 84. TABLE 20 LATIN AMERICA: GENOTYPING ASSAY REAGENTS & KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 85. TABLE 21 GENOTYPING ASSAY SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION) 86. TABLE 22 NORTH AMERICA: GENOTYPING ASSAY SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 86. TABLE 23 EUROPE: GENOTYPING ASSAY SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 87. TABLE 24 ASIA PACIFIC: GENOTYPING ASSAY SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 87. TABLE 25 LATIN AMERICA: GENOTYPING ASSAY SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 88. TABLE 26 GENOTYPING ASSAY INSTRUMENTS MARKET, BY REGION, 2023–2031 (USD MILLION) 89. TABLE 27 NORTH AMERICA: GENOTYPING ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 89. TABLE 28 EUROPE: GENOTYPING ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 90. TABLE 29 ASIA PACIFIC: GENOTYPING ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 90. TABLE 30 LATIN AMERICA: GENOTYPING ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 91. TABLE 31 GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 91. TABLE 32 GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY REGION, 2023–2031 (USD MILLION) 92. TABLE 33 NORTH AMERICA: GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 92. TABLE 34 EUROPE: GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 93. TABLE 35 ASIA PACIFIC: GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 93. TABLE 36 LATIN AMERICA: GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 94. TABLE 37 GENOTYPING ASSAY ANALYZERS MARKET, BY REGION, 2023–2031 (USD MILLION) 95. TABLE 38 NORTH AMERICA: GENOTYPING ASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 95. TABLE 39 EUROPE: GENOTYPING ASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 96. TABLE 40 ASIA PACIFIC: GENOTYPING ASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 96. TABLE 41 LATIN AMERICA: GENOTYPING ASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 97. TABLE 42 GENOTYPING ASSAY BIOINFORMATICS MARKET, BY REGION, 2023–2031 (USD MILLION) 97. TABLE 43 NORTH AMERICA: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 98. TABLE 44 EUROPE: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 98. TABLE 45 ASIA PACIFIC: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 99. TABLE 46 LATIN AMERICA: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 99. TABLE 47 GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 99. TABLE 48 GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY REGION, 2023–2031 (USD MILLION) 100. TABLE 49 NORTH AMERICA: GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 101. TABLE 50 EUROPE: GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 101. TABLE 51 ASIA PACIFIC: GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 102. TABLE 52 LATIN AMERICA: GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 102. TABLE 53 GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION) 103. TABLE 54 NORTH AMERICA: GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 103. TABLE 55 EUROPE: GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 104. TABLE 56 ASIA PACIFIC: GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 104. TABLE 57 LATIN AMERICA: GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 105. TABLE 58 GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 107. TABLE 59 COMPARATIVE STUDY: REAL-TIME POLYMERASE CHAIN REACTION VS. DIGITAL POLYMERASE CHAIN REACTION 108. TABLE 60 GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 109. TABLE 61 GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2031 (USD MILLION) 109. TABLE 62 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2031 (USD MILLION) 109. TABLE 63 EUROPE: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2031 (USD MILLION) 110. TABLE 64 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2031 (USD MILLION) 110. TABLE 65 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2031 (USD MILLION) 111. TABLE 66 KEY REAL-TIME POLYMERASE CHAIN REACTION PRODUCTS 111. TABLE 67 REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY REGION, 2023–2031 (USD MILLION) 113. TABLE 68 NORTH AMERICA: REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 113. TABLE 69 EUROPE: REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 114. TABLE 70 ASIA PACIFIC: REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 114. TABLE 71 LATIN AMERICA: REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115. TABLE 72 KEY DIGITAL POLYMERASE CHAIN REACTION PRODUCTS 116. TABLE 73 DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2023–2031 (USD MILLION) 116. TABLE 74 NORTH AMERICA: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 117. TABLE 75 EUROPE: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 117. TABLE 76 ASIA PACIFIC: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118. TABLE 77 LATIN AMERICA: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118. TABLE 78 KEY MICROARRAYS 119. TABLE 79 GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY REGION, 2023–2031 (USD MILLION) 120. TABLE 80 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2031 (USD MILLION) 121. TABLE 81 EUROPE: GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2031 (USD MILLION) 121. TABLE 82 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2031 (USD MILLION) 122. TABLE 83 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2031 (USD MILLION) 122. TABLE 84 GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 123. TABLE 85 GENOTYPING ASSAY MARKET FOR SEQUENCING, BY REGION, 2023–2031 (USD MILLION) 123. TABLE 86 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION) 124. TABLE 87 EUROPE: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION) 124. TABLE 88 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION) 125. TABLE 89 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION) 125. TABLE 90 KEY NEXT-GENERATION SEQUENCING PRODUCTS 126. TABLE 91 NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2023–2031 (USD MILLION) 127. TABLE 92 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 128. TABLE 93 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 128. TABLE 94 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 129. TABLE 95 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 129. TABLE 96 KEY PYROSEQUENCING PRODUCTS 130. TABLE 97 PYROSEQUENCING MARKET, BY REGION, 2023–2031 (USD MILLION) 130. TABLE 98 NORTH AMERICA: PYROSEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 131. TABLE 99 EUROPE: PYROSEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 131. TABLE 100 ASIA PACIFIC: PYROSEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 132. TABLE 101 LATIN AMERICA: PYROSEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 132. TABLE 102 KEY SANGER SEQUENCING PRODUCTS 133. TABLE 103 SANGER SEQUENCING MARKET, BY REGION, 2023–2031 (USD MILLION) 133. TABLE 104 NORTH AMERICA: SANGER SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 134. TABLE 105 EUROPE: SANGER SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 134. TABLE 106 ASIA PACIFIC: SANGER SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 135. TABLE 107 LATIN AMERICA: SANGER SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 135. TABLE 108 GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 136. TABLE 109 GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION, 2023–2031 (USD MILLION) 136. TABLE 110 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2023–2031 (USD MILLION) 137. TABLE 111 EUROPE: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2023–2031 (USD MILLION) 137. TABLE 112 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2023–2031 (USD MILLION) 138. TABLE 113 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2023–2031 (USD MILLION) 138. TABLE 114 AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY REGION, 2023–2031 (USD MILLION) 139. TABLE 115 NORTH AMERICA: AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 139. TABLE 116 EUROPE: AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 140. TABLE 117 ASIA PACIFIC: AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 140. TABLE 118 LATIN AMERICA: AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 141. TABLE 119 KEY RESTRICTION FRAGMENT LENGTH POLYMORPHISM PRODUCTS 141. TABLE 120 RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY REGION, 2023–2031 (USD MILLION) 142. TABLE 121 NORTH AMERICA: RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 142. TABLE 122 EUROPE: RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 143. TABLE 123 ASIA PACIFIC: RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 143. TABLE 124 LATIN AMERICA: RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 144. TABLE 125 KEY SINGLE-STRAND CONFORMATION POLYMORPHISM PRODUCTS 144. TABLE 126 SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY REGION, 2023–2031 (USD MILLION) 145. TABLE 127 NORTH AMERICA: SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 145. TABLE 128 EUROPE: SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 146. TABLE 129 ASIA PACIFIC: SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 146. TABLE 130 LATIN AMERICA: SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 147. TABLE 131 KEY MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY PRODUCTS 148. TABLE 132 GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY REGION, 2023–2031 (USD MILLION) 148. TABLE 133 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2023–2031 (USD MILLION) 149. TABLE 134 EUROPE: GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2023–2031 (USD MILLION) 149. TABLE 135 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2023–2031 (USD MILLION) 150. TABLE 136 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2023–2031 (USD MILLION) 150. TABLE 137 OTHER GENOTYPING PRODUCTS 151. TABLE 138 GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2031 (USD MILLION) 151. TABLE 139 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION) 152. TABLE 140 EUROPE: GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION) 152. TABLE 141 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION) 153. TABLE 142 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION) 153. TABLE 143 GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 155. TABLE 144 GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY REGION, 2023–2031 (USD MILLION) 156. TABLE 145 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2023–2031 (USD MILLION) 156. TABLE 146 EUROPE: GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2023–2031 (USD MILLION) 156. TABLE 147 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2023–2031 (USD MILLION) 157. TABLE 148 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2023–2031 (USD MILLION) 158. TABLE 149 GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY REGION, 2023–2031 (USD MILLION) 159. TABLE 150 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION) 159. TABLE 151 EUROPE: GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION) 160. TABLE 152 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION) 160. TABLE 153 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION) 161. TABLE 154 GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS, BY REGION, 2023–2031 (USD MILLION) 162. TABLE 155 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS, BY COUNTRY, 2023–2031 (USD MILLION) 162. TABLE 156 EUROPE: GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS BY COUNTRY, 2023–2031 (USD MILLION) 163. TABLE 157 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS, BY COUNTRY, 2023–2031 (USD MILLION) 163. TABLE 158 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS, BY COUNTRY, 2023–2031 (USD MILLION) 164. TABLE 159 GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2023–2031 (USD MILLION) 165. TABLE 160 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 165. TABLE 161 EUROPE: GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 166. TABLE 162 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY BY COUNTRY, 2023–2031 (USD MILLION) 166. TABLE 163 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 167. TABLE 164 GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2031 (USD MILLION) 167. TABLE 165 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION) 168. TABLE 166 EUROPE: GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2023–2031 (USD MILLION) 168. TABLE 167 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION) 169. TABLE 168 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION) 169. TABLE 169 GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 171. TABLE 170 GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2031 (USD MILLION) 172. TABLE 171 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 172. TABLE 172 EUROPE: GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 173. TABLE 173 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 173. TABLE 174 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 174. TABLE 175 GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2023–2031 (USD MILLION) 175. TABLE 176 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION) 175. TABLE 177 EUROPE: GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION) 176. TABLE 178 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION) 176. TABLE 179 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION) 177. TABLE 180 GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION) 178. TABLE 181 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 178. TABLE 182 EUROPE: GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 179. TABLE 183 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 179. TABLE 184 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 180. TABLE 185 GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION) 181. TABLE 186 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 181. TABLE 187 EUROPE: GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 182. TABLE 188 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 182. TABLE 189 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 183. TABLE 190 GENOTYPING ASSAY MARKET, BY REGION, 2023–2031 (USD MILLION) 185. TABLE 191 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 186. TABLE 192 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 187. TABLE 193 NORTH AMERICA: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 187. TABLE 194 NORTH AMERICA: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 187. TABLE 195 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 188. TABLE 196 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 188. TABLE 197 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 189. TABLE 198 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 189. TABLE 199 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 190. TABLE 200 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 190. TABLE 201 US: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 191. TABLE 202 US: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 192. TABLE 203 US: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 192. TABLE 204 US: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 193. TABLE 205 US: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 193. TABLE 206 US: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 194. TABLE 207 US: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 194. TABLE 208 US: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 195. TABLE 209 US: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 195. TABLE 210 CANADA: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 196. TABLE 211 CANADA: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 197. TABLE 212 CANADA: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 197. TABLE 213 CANADA: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 198. TABLE 214 CANADA: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 198. TABLE 215 CANADA: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 199. TABLE 216 CANADA: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 199. TABLE 217 CANADA: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 200. TABLE 218 CANADA: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 200. TABLE 219 EUROPE: GENOTYPING ASSAY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 202. TABLE 220 EUROPE: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 202. TABLE 221 EUROPE: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 203. TABLE 222 EUROPE: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 203. TABLE 223 EUROPE: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 204. TABLE 224 EUROPE: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 204. TABLE 225 EUROPE: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 205. TABLE 226 EUROPE: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 205. TABLE 227 EUROPE: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 206. TABLE 228 EUROPE: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 206. TABLE 229 GERMANY: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 207. TABLE 230 GERMANY: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 208. TABLE 231 GERMANY: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 208. TABLE 232 GERMANY: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 209. TABLE 233 GERMANY: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 209. TABLE 234 GERMANY: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 210. TABLE 235 GERMANY: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 210. TABLE 236 GERMANY: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 211. TABLE 237 GERMANY: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 211. TABLE 238 UK: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 212. TABLE 239 UK: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 212. TABLE 240 UK: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 213. TABLE 241 UK: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 213. TABLE 242 UK: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 214. TABLE 243 UK: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 214. TABLE 244 UK: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 215. TABLE 245 UK: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 215. TABLE 246 UK: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 216. TABLE 247 FRANCE: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 217. TABLE 248 FRANCE: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 217. TABLE 249 FRANCE: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 218. TABLE 250 FRANCE: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 218. TABLE 251 FRANCE: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 219. TABLE 252 FRANCE: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 219. TABLE 253 FRANCE: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 220. TABLE 254 FRANCE: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 220. TABLE 255 FRANCE: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 221. TABLE 256 ITALY: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 222. TABLE 257 ITALY: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 222. TABLE 258 ITALY: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 223. TABLE 259 ITALY: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 223. TABLE 260 ITALY: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 224. TABLE 261 ITALY: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 224. TABLE 262 ITALY: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 225. TABLE 263 ITALY: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 225. TABLE 264 ITALY: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 226. TABLE 265 SPAIN: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 227. TABLE 266 SPAIN: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 227. TABLE 267 SPAIN: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 228. TABLE 268 SPAIN: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 228. TABLE 269 SPAIN: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 229. TABLE 270 SPAIN: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 229. TABLE 271 SPAIN: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 230. TABLE 272 SPAIN: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 230. TABLE 273 SPAIN: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 231. TABLE 274 REST OF EUROPE: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 232. TABLE 275 REST OF EUROPE: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 232. TABLE 276 REST OF EUROPE: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 232. TABLE 277 REST OF EUROPE: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 233. TABLE 278 REST OF EUROPE: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 233. TABLE 279 REST OF EUROPE: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 234. TABLE 280 REST OF EUROPE: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 234. TABLE 281 REST OF EUROPE: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 235. TABLE 282 REST OF EUROPE: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 235. TABLE 283 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 237. TABLE 284 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 237. TABLE 285 ASIA PACIFIC: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 238. TABLE 286 ASIA PACIFIC: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 238. TABLE 287 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 239. TABLE 288 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 239. TABLE 289 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 240. TABLE 290 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 240. TABLE 291 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 241. TABLE 292 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 241. TABLE 293 CHINA: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 242.
SummaryThe global genotyping assays market is projected to reach USD 44.60 billion by 2031, up from USD 24.29 billion in 2026, reflecting a 12.9% CAGR over the forecast period. Market growth is driven by advances in DNA sequencing, rising prevalence of genetic disorders, growing adoption of personalized medicine, and expanding use of genotyping in drug discovery and development. Ongoing innovation in PCR-based assays, microarray technologies, sequencing platforms, and bioinformatics solutions is further supporting market adoption. However, high instrument acquisition and maintenance costs, data management challenges, concerns about genetic data privacy, and a shortage of trained professionals in genomic analysis are expected to restrain broader market growth. The reagents & kits segment accounted for the largest share of the genotyping assays market, by product, in 2025. The sequencing segment is projected to be the fastest-growing segment of the genotyping assays market, by technology, from 2026 to 2031. Asia Pacific is projected to grow at the highest CAGR in the genotyping assays market from 2026 to 2031. The primary interviews conducted for this report can be categorized as follows: List of Companies Profiled in the Report Research Coverage Key Benefits of Buying the Report The report provides insights into the following pointers: Table of Contents1 INTRODUCTION 33 2 EXECUTIVE SUMMARY 38 3 PREMIUM INSIGHTS 45 4 MARKET OVERVIEW 49 5 GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE 81 6 GENOTYPING ASSAY MARKET, BY TECHNOLOGY 106 7 GENOTYPING ASSAY MARKET, BY APPLICATION 154 8 GENOTYPING ASSAY MARKET, BY END USER 170 9 GENOTYPING ASSAY MARKET, BY REGION 184 10 COMPETITIVE LANDSCAPE 286 11 COMPANY PROFILES 303 12 RESEARCH METHODOLOGY 382 13 APPENDIX 394 List of Tables/GraphsFIGURE 1 GENOTYPING ASSAY MARKET: MARKET SEGMENTATION AND REGIONAL SCOPE 34.FIGURE 2 GENOTYPING ASSAY MARKET: YEARS CONSIDERED 36. FIGURE 3 MARKET SCENARIO 39. FIGURE 4 GLOBAL GENOTYPING ASSAY MARKET, 2023–2031 39. FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN GENOTYPING ASSAY MARKET, JANUARY 2023–OCTOBER 2026 40. FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF GENOTYPING ASSAY MARKET 41. FIGURE 7 HIGH-GROWTH SEGMENTS IN GENOTYPING ASSAY MARKET, 2026–2031 42. FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN GENOTYPING ASSAY MARKET DURING FORECAST PERIOD 43. FIGURE 9 GROWING GENOMIC TESTING INFRASTRUCTURE TO PROPEL MARKET GROWTH 45. FIGURE 10 REAGENTS & KITS SEGMENT ACCOUNTED FOR LARGEST SHARE OF GENOTYPING ASSAY MARKET IN NORTH AMERICA IN 2025 46. FIGURE 11 JAPAN TO BE FASTEST-GROWING COUNTRY IN GENOTYPING ASSAY MARKET DURING FORECAST PERIOD 47. FIGURE 12 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 48. FIGURE 13 GENOTYPING ASSAY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49. FIGURE 14 GENOTYPING ASSAY MARKET: PORTER’S FIVE FORCES ANALYSIS 57. FIGURE 15 GENOTYPING ASSAY MARKET: VALUE CHAIN ANALYSIS 61. FIGURE 16 GENOTYPING ASSAY MARKET ECOSYSTEM 62. FIGURE 17 PATENT APPLICATIONS FOR GENOTYPING ASSAY MARKET, JANUARY 2015–JANUARY 2025 66. FIGURE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 68. FIGURE 19 KEY BUYING CRITERIA FOR GENOTYPING ASSAYS 69. FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75. FIGURE 21 NORTH AMERICA: GENOTYPING ASSAY MARKET SNAPSHOT 186. FIGURE 22 ASIA PACIFIC: GENOTYPING ASSAY MARKET SNAPSHOT 236. FIGURE 23 REVENUE ANALYSIS OF KEY PLAYERS IN GENOTYPING. ASSAY MARKET, 2023–2025 288. FIGURE 24 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GENOTYPING. ASSAY MARKET, 2025 289. FIGURE 25 GENOTYPING ASSAY MARKET: COMPANY EVALUATION MATRIX. (KEY PLAYERS), 2025 291. FIGURE 26 GENOTYPING ASSAY MARKET: COMPANY FOOTPRINT 292. FIGURE 27 GENOTYPING ASSAY MARKET: COMPANY EVALUATION MATRIX. (STARTUPS/SMES), 2025 296. FIGURE 28 EV/EBITDA OF KEY VENDORS 298. FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 298. FIGURE 30 GENOTYPING ASSAY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 299. FIGURE 31 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 304. FIGURE 32 ILLUMINA, INC.: COMPANY SNAPSHOT (2025) 312. FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 323. FIGURE 34 QIAGEN: COMPANY SNAPSHOT (2025) 329. FIGURE 35 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 337. FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025) 342. FIGURE 37 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 346. FIGURE 38 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 354. FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2025) 360. FIGURE 40 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2025) 365. FIGURE 41 GENOTYPING ASSAY MARKET: RESEARCH DESIGN 382. FIGURE 42 KEY PRIMARY SOURCES: DEMAND AND SUPPLY SIDES 384. FIGURE 43 GENOTYPING ASSAY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025 385. FIGURE 44 GENOTYPING ASSAY MARKET ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025 386. FIGURE 45 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2025) 386. FIGURE 46 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 387. FIGURE 47 SEGMENTAL MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN 388. FIGURE 48 GENOTYPING ASSAY MARKET: CAGR PROJECTIONS 389. FIGURE 49 DATA TRIANGULATION METHODOLOGY 391. TABLE 1 GENOTYPING ASSAY MARKET: INCLUSIONS & EXCLUSIONS 35. TABLE 2 GENOTYPING ASSAY MARKET: IMPACT ANALYSIS 50. TABLE 3 HUMAN GENOME SEQUENCING COST TIMELINE, 2003–2025 51. TABLE 4 GENOTYPING ASSAY MARKET: PORTER’S FIVE FORCES ANALYSIS 57. TABLE 5 GENOTYPING ASSAY MARKET: ROLE IN ECOSYSTEM 62. TABLE 6 AVERAGE SELLING PRICE OF GENOTYPING ASSAY PRODUCTS, BY KEY PLAYER, 2021–2025 64. TABLE 7 AVERAGE SELLING PRICE OF GENOTYPING ASSAY PRODUCTS,. BY REGION, 2021–2025 65. TABLE 8 INDICATIVE LIST OF PATENTS IN GENOTYPING ASSAY MARKET 67. TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 68. TABLE 10 KEY BUYING CRITERIA FOR GENOTYPING ASSAYS 69. TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION 71. TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71. TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES 72. TABLE 14 GENOTYPING ASSAY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 75. TABLE 15 GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 82. TABLE 16 GENOTYPING ASSAY REAGENTS & KITS MARKET, BY REGION, 2023–2031 (USD MILLION) 83. TABLE 17 NORTH AMERICA: GENOTYPING ASSAY REAGENTS & KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 83. TABLE 18 EUROPE: GENOTYPING ASSAY REAGENTS & KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 84. TABLE 19 ASIA PACIFIC: GENOTYPING ASSAY REAGENTS & KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 84. TABLE 20 LATIN AMERICA: GENOTYPING ASSAY REAGENTS & KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 85. TABLE 21 GENOTYPING ASSAY SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION) 86. TABLE 22 NORTH AMERICA: GENOTYPING ASSAY SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 86. TABLE 23 EUROPE: GENOTYPING ASSAY SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 87. TABLE 24 ASIA PACIFIC: GENOTYPING ASSAY SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 87. TABLE 25 LATIN AMERICA: GENOTYPING ASSAY SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 88. TABLE 26 GENOTYPING ASSAY INSTRUMENTS MARKET, BY REGION, 2023–2031 (USD MILLION) 89. TABLE 27 NORTH AMERICA: GENOTYPING ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 89. TABLE 28 EUROPE: GENOTYPING ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 90. TABLE 29 ASIA PACIFIC: GENOTYPING ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 90. TABLE 30 LATIN AMERICA: GENOTYPING ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 91. TABLE 31 GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 91. TABLE 32 GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY REGION, 2023–2031 (USD MILLION) 92. TABLE 33 NORTH AMERICA: GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 92. TABLE 34 EUROPE: GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 93. TABLE 35 ASIA PACIFIC: GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 93. TABLE 36 LATIN AMERICA: GENOTYPING ASSAY SEQUENCERS & AMPLIFIERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 94. TABLE 37 GENOTYPING ASSAY ANALYZERS MARKET, BY REGION, 2023–2031 (USD MILLION) 95. TABLE 38 NORTH AMERICA: GENOTYPING ASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 95. TABLE 39 EUROPE: GENOTYPING ASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 96. TABLE 40 ASIA PACIFIC: GENOTYPING ASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 96. TABLE 41 LATIN AMERICA: GENOTYPING ASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 97. TABLE 42 GENOTYPING ASSAY BIOINFORMATICS MARKET, BY REGION, 2023–2031 (USD MILLION) 97. TABLE 43 NORTH AMERICA: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 98. TABLE 44 EUROPE: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 98. TABLE 45 ASIA PACIFIC: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 99. TABLE 46 LATIN AMERICA: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 99. TABLE 47 GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 99. TABLE 48 GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY REGION, 2023–2031 (USD MILLION) 100. TABLE 49 NORTH AMERICA: GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 101. TABLE 50 EUROPE: GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 101. TABLE 51 ASIA PACIFIC: GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 102. TABLE 52 LATIN AMERICA: GENOTYPING ASSAY BIOINFORMATICS SOFTWARE MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 102. TABLE 53 GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION) 103. TABLE 54 NORTH AMERICA: GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 103. TABLE 55 EUROPE: GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 104. TABLE 56 ASIA PACIFIC: GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 104. TABLE 57 LATIN AMERICA: GENOTYPING ASSAY BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 105. TABLE 58 GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 107. TABLE 59 COMPARATIVE STUDY: REAL-TIME POLYMERASE CHAIN REACTION VS. DIGITAL POLYMERASE CHAIN REACTION 108. TABLE 60 GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 109. TABLE 61 GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2031 (USD MILLION) 109. TABLE 62 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2031 (USD MILLION) 109. TABLE 63 EUROPE: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2031 (USD MILLION) 110. TABLE 64 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2031 (USD MILLION) 110. TABLE 65 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2031 (USD MILLION) 111. TABLE 66 KEY REAL-TIME POLYMERASE CHAIN REACTION PRODUCTS 111. TABLE 67 REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY REGION, 2023–2031 (USD MILLION) 113. TABLE 68 NORTH AMERICA: REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 113. TABLE 69 EUROPE: REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 114. TABLE 70 ASIA PACIFIC: REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 114. TABLE 71 LATIN AMERICA: REAL-TIME POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115. TABLE 72 KEY DIGITAL POLYMERASE CHAIN REACTION PRODUCTS 116. TABLE 73 DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2023–2031 (USD MILLION) 116. TABLE 74 NORTH AMERICA: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 117. TABLE 75 EUROPE: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 117. TABLE 76 ASIA PACIFIC: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118. TABLE 77 LATIN AMERICA: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 118. TABLE 78 KEY MICROARRAYS 119. TABLE 79 GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY REGION, 2023–2031 (USD MILLION) 120. TABLE 80 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2031 (USD MILLION) 121. TABLE 81 EUROPE: GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2031 (USD MILLION) 121. TABLE 82 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2031 (USD MILLION) 122. TABLE 83 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR MICROARRAYS, BY COUNTRY, 2023–2031 (USD MILLION) 122. TABLE 84 GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 123. TABLE 85 GENOTYPING ASSAY MARKET FOR SEQUENCING, BY REGION, 2023–2031 (USD MILLION) 123. TABLE 86 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION) 124. TABLE 87 EUROPE: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION) 124. TABLE 88 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION) 125. TABLE 89 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY COUNTRY, 2023–2031 (USD MILLION) 125. TABLE 90 KEY NEXT-GENERATION SEQUENCING PRODUCTS 126. TABLE 91 NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2023–2031 (USD MILLION) 127. TABLE 92 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 128. TABLE 93 EUROPE: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 128. TABLE 94 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 129. TABLE 95 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 129. TABLE 96 KEY PYROSEQUENCING PRODUCTS 130. TABLE 97 PYROSEQUENCING MARKET, BY REGION, 2023–2031 (USD MILLION) 130. TABLE 98 NORTH AMERICA: PYROSEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 131. TABLE 99 EUROPE: PYROSEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 131. TABLE 100 ASIA PACIFIC: PYROSEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 132. TABLE 101 LATIN AMERICA: PYROSEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 132. TABLE 102 KEY SANGER SEQUENCING PRODUCTS 133. TABLE 103 SANGER SEQUENCING MARKET, BY REGION, 2023–2031 (USD MILLION) 133. TABLE 104 NORTH AMERICA: SANGER SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 134. TABLE 105 EUROPE: SANGER SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 134. TABLE 106 ASIA PACIFIC: SANGER SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 135. TABLE 107 LATIN AMERICA: SANGER SEQUENCING MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 135. TABLE 108 GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 136. TABLE 109 GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION, 2023–2031 (USD MILLION) 136. TABLE 110 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2023–2031 (USD MILLION) 137. TABLE 111 EUROPE: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2023–2031 (USD MILLION) 137. TABLE 112 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2023–2031 (USD MILLION) 138. TABLE 113 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2023–2031 (USD MILLION) 138. TABLE 114 AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY REGION, 2023–2031 (USD MILLION) 139. TABLE 115 NORTH AMERICA: AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 139. TABLE 116 EUROPE: AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 140. TABLE 117 ASIA PACIFIC: AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 140. TABLE 118 LATIN AMERICA: AMPLIFIED FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 141. TABLE 119 KEY RESTRICTION FRAGMENT LENGTH POLYMORPHISM PRODUCTS 141. TABLE 120 RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY REGION, 2023–2031 (USD MILLION) 142. TABLE 121 NORTH AMERICA: RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 142. TABLE 122 EUROPE: RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 143. TABLE 123 ASIA PACIFIC: RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 143. TABLE 124 LATIN AMERICA: RESTRICTION FRAGMENT LENGTH POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 144. TABLE 125 KEY SINGLE-STRAND CONFORMATION POLYMORPHISM PRODUCTS 144. TABLE 126 SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY REGION, 2023–2031 (USD MILLION) 145. TABLE 127 NORTH AMERICA: SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 145. TABLE 128 EUROPE: SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 146. TABLE 129 ASIA PACIFIC: SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 146. TABLE 130 LATIN AMERICA: SINGLE-STRAND CONFORMATION POLYMORPHISM MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 147. TABLE 131 KEY MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY PRODUCTS 148. TABLE 132 GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY REGION, 2023–2031 (USD MILLION) 148. TABLE 133 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2023–2031 (USD MILLION) 149. TABLE 134 EUROPE: GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2023–2031 (USD MILLION) 149. TABLE 135 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2023–2031 (USD MILLION) 150. TABLE 136 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT MASS SPECTROMETRY, BY COUNTRY, 2023–2031 (USD MILLION) 150. TABLE 137 OTHER GENOTYPING PRODUCTS 151. TABLE 138 GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2031 (USD MILLION) 151. TABLE 139 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION) 152. TABLE 140 EUROPE: GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION) 152. TABLE 141 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION) 153. TABLE 142 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION) 153. TABLE 143 GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 155. TABLE 144 GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY REGION, 2023–2031 (USD MILLION) 156. TABLE 145 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2023–2031 (USD MILLION) 156. TABLE 146 EUROPE: GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2023–2031 (USD MILLION) 156. TABLE 147 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2023–2031 (USD MILLION) 157. TABLE 148 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2023–2031 (USD MILLION) 158. TABLE 149 GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY REGION, 2023–2031 (USD MILLION) 159. TABLE 150 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION) 159. TABLE 151 EUROPE: GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION) 160. TABLE 152 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION) 160. TABLE 153 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR DIAGNOSTICS & PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION) 161. TABLE 154 GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS, BY REGION, 2023–2031 (USD MILLION) 162. TABLE 155 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS, BY COUNTRY, 2023–2031 (USD MILLION) 162. TABLE 156 EUROPE: GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS BY COUNTRY, 2023–2031 (USD MILLION) 163. TABLE 157 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS, BY COUNTRY, 2023–2031 (USD MILLION) 163. TABLE 158 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR ANIMAL GENETICS, BY COUNTRY, 2023–2031 (USD MILLION) 164. TABLE 159 GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2023–2031 (USD MILLION) 165. TABLE 160 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 165. TABLE 161 EUROPE: GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 166. TABLE 162 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY BY COUNTRY, 2023–2031 (USD MILLION) 166. TABLE 163 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR AGRICULTURAL BIOTECHNOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 167. TABLE 164 GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2031 (USD MILLION) 167. TABLE 165 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION) 168. TABLE 166 EUROPE: GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2023–2031 (USD MILLION) 168. TABLE 167 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION) 169. TABLE 168 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION) 169. TABLE 169 GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 171. TABLE 170 GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2031 (USD MILLION) 172. TABLE 171 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 172. TABLE 172 EUROPE: GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 173. TABLE 173 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 173. TABLE 174 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 174. TABLE 175 GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2023–2031 (USD MILLION) 175. TABLE 176 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION) 175. TABLE 177 EUROPE: GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION) 176. TABLE 178 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION) 176. TABLE 179 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2031 (USD MILLION) 177. TABLE 180 GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION) 178. TABLE 181 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 178. TABLE 182 EUROPE: GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 179. TABLE 183 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 179. TABLE 184 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 180. TABLE 185 GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION) 181. TABLE 186 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 181. TABLE 187 EUROPE: GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 182. TABLE 188 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 182. TABLE 189 LATIN AMERICA: GENOTYPING ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 183. TABLE 190 GENOTYPING ASSAY MARKET, BY REGION, 2023–2031 (USD MILLION) 185. TABLE 191 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 186. TABLE 192 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 187. TABLE 193 NORTH AMERICA: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 187. TABLE 194 NORTH AMERICA: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 187. TABLE 195 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 188. TABLE 196 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 188. TABLE 197 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 189. TABLE 198 NORTH AMERICA: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 189. TABLE 199 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 190. TABLE 200 NORTH AMERICA: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 190. TABLE 201 US: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 191. TABLE 202 US: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 192. TABLE 203 US: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 192. TABLE 204 US: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 193. TABLE 205 US: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 193. TABLE 206 US: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 194. TABLE 207 US: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 194. TABLE 208 US: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 195. TABLE 209 US: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 195. TABLE 210 CANADA: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 196. TABLE 211 CANADA: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 197. TABLE 212 CANADA: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 197. TABLE 213 CANADA: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 198. TABLE 214 CANADA: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 198. TABLE 215 CANADA: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 199. TABLE 216 CANADA: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 199. TABLE 217 CANADA: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 200. TABLE 218 CANADA: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 200. TABLE 219 EUROPE: GENOTYPING ASSAY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 202. TABLE 220 EUROPE: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 202. TABLE 221 EUROPE: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 203. TABLE 222 EUROPE: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 203. TABLE 223 EUROPE: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 204. TABLE 224 EUROPE: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 204. TABLE 225 EUROPE: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 205. TABLE 226 EUROPE: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 205. TABLE 227 EUROPE: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 206. TABLE 228 EUROPE: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 206. TABLE 229 GERMANY: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 207. TABLE 230 GERMANY: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 208. TABLE 231 GERMANY: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 208. TABLE 232 GERMANY: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 209. TABLE 233 GERMANY: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 209. TABLE 234 GERMANY: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 210. TABLE 235 GERMANY: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 210. TABLE 236 GERMANY: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 211. TABLE 237 GERMANY: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 211. TABLE 238 UK: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 212. TABLE 239 UK: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 212. TABLE 240 UK: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 213. TABLE 241 UK: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 213. TABLE 242 UK: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 214. TABLE 243 UK: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 214. TABLE 244 UK: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 215. TABLE 245 UK: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 215. TABLE 246 UK: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 216. TABLE 247 FRANCE: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 217. TABLE 248 FRANCE: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 217. TABLE 249 FRANCE: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 218. TABLE 250 FRANCE: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 218. TABLE 251 FRANCE: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 219. TABLE 252 FRANCE: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 219. TABLE 253 FRANCE: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 220. TABLE 254 FRANCE: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 220. TABLE 255 FRANCE: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 221. TABLE 256 ITALY: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 222. TABLE 257 ITALY: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 222. TABLE 258 ITALY: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 223. TABLE 259 ITALY: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 223. TABLE 260 ITALY: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 224. TABLE 261 ITALY: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 224. TABLE 262 ITALY: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 225. TABLE 263 ITALY: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 225. TABLE 264 ITALY: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 226. TABLE 265 SPAIN: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 227. TABLE 266 SPAIN: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 227. TABLE 267 SPAIN: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 228. TABLE 268 SPAIN: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 228. TABLE 269 SPAIN: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 229. TABLE 270 SPAIN: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 229. TABLE 271 SPAIN: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 230. TABLE 272 SPAIN: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 230. TABLE 273 SPAIN: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 231. TABLE 274 REST OF EUROPE: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 232. TABLE 275 REST OF EUROPE: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 232. TABLE 276 REST OF EUROPE: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 232. TABLE 277 REST OF EUROPE: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 233. TABLE 278 REST OF EUROPE: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 233. TABLE 279 REST OF EUROPE: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 234. TABLE 280 REST OF EUROPE: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 234. TABLE 281 REST OF EUROPE: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 235. TABLE 282 REST OF EUROPE: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 235. TABLE 283 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 237. TABLE 284 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 237. TABLE 285 ASIA PACIFIC: GENOTYPING ASSAY INSTRUMENTS MARKET, BY TYPE, 2023–2031 (USD MILLION) 238. TABLE 286 ASIA PACIFIC: GENOTYPING ASSAY BIOINFORMATICS MARKET, BY TYPE, 2023–2031 (USD MILLION) 238. TABLE 287 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION) 239. TABLE 288 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR POLYMERASE CHAIN REACTION, BY TYPE, 2023–2031 (USD MILLION) 239. TABLE 289 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR SEQUENCING, BY TYPE, 2023–2031 (USD MILLION) 240. TABLE 290 ASIA PACIFIC: GENOTYPING ASSAY MARKET FOR CAPILLARY ELECTROPHORESIS, BY TYPE, 2023–2031 (USD MILLION) 240. TABLE 291 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 241. TABLE 292 ASIA PACIFIC: GENOTYPING ASSAY MARKET, BY END USER, 2023–2031 (USD MILLION) 241. TABLE 293 CHINA: GENOTYPING ASSAY MARKET, BY PRODUCT & SERVICE, 2023–2031 (USD MILLION) 242.
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
MarketsandMarkets社の Biotechnology分野 での最新刊レポート
本レポートと同じKEY WORD(assay)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|